share_log
Moomoo 24/7 ·  Oct 30, 2023 08:07
Armata Pharmaceuticals Announces Presentation of Topline Data From SWARM-P.a. Clinical Study Of AP-PA02 For Chronic Pulmonary Pseudomonas Aeruginosa Infections In Cystic Fibrosis Patients At North American Cystic Fibrosis Conference
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment